Bioequivalence Study of Two Formulations of Lisinopril Tablet 20 mg in Healthy Volunteers Under Fasting Conditions

NCT05061901 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Lisinopril tablet 20 mg
DRUG: Zestril® tablet 20 mg

Sponsor

Pharmtechnology LLC

Collaborators

[object Object]